Educational needs of oncology pharmacists: A survey by the International Society of Oncology Pharmacy Practitioners

Abstract

Background

The International Society of Oncology Pharmacy Practitioners (ISOPP) is committed to providing educational resources to members for their continuous learning and professional development. This survey was conducted to explore the educational needs of International Society of Oncology Pharmacy Practitioners members for the purpose of developing resources to support future learning relevant to the diverse global pharmacy practitioner membership of our society.

Methods

A cross-sectional survey of International Society of Oncology Pharmacy Practitioners membership was conducted between 10 December 2018 and 15 January 2019. The survey contained 17 questions and consisted of four sections: (1) respondents’ demographics, (2) common challenges/barriers faced by members in accessing oncology pharmacy education, (3) areas within oncology pharmacy where members need education and (4) preferred methods of education delivery. Descriptive statistics were utilized to summarize survey results.

Results

The survey was completed by 62 out of 363 International Society of Oncology Pharmacy Practitioners members (17% response rate). Respondents were from 19 different countries, representing all the habitable continents. Most respondents were practicing in North America (21%), Oceania (21%) and Asia (16%). The majority of respondents worked in inpatient cancer units (60%), ambulatory tertiary cancer centres (31%) and academia (26%). Reported barriers to accessing education relevant to oncology pharmacy practice included lack of financial support (44%), time spent travelling to attend educational activities (39%), limited learning opportunities in their country of practice (34%) and limited growth of the oncology pharmacy discipline in their country of practice (32%). The content areas of greatest demand included pharmacotherapy of various cancers followed by oncology pharmacy research, International Society of Oncology Pharmacy Practitioners oncology pharmacy practice standards, supportive care and medication safety. Among educational activities offered by International Society of Oncology Pharmacy Practitioners, respondents valued annual International Society of Oncology Pharmacy Practitioners symposia and Journal of Oncology Pharmacy Practice the most. Most respondents (87%) indicated webinars as an effective educational tool.

Conclusion

Among an international oncology pharmacist cohort, we identified practice areas prioritized by pharmacists for continuing and professional development. Time and cost were common barriers to education, both in developing and developed countries. These survey findings may help to guide future education initiatives of International Society of Oncology Pharmacy Practitioners and other providers of pharmacist oncology education.

Keywords

Oncology education pharmacist pharmacy educational resources learning preferences continuing professional development

Get full access to this article

View all access options for this article.

References

Hematology Oncology Pharmacy Association. The role of hematology/oncology pharmacists, www.hoparx.org/images/hopa/advocacy/Access-to-pharmacists care/HOPA_About_Hem_Onc_Pharmacist_Issue_Brief_FINAL.pdf (2020, accessed 19 March 2020).

Sessions

Valgus

Barbour

, et al. Role of oncology clinical pharmacists in light of the oncology workforce study. J Oncol Pract 2010; 6: 270–272.

McAneny

Stevenson

D’Amato

, et al. Clinical pharmacists in oncology practice. J Oncol Pract 2008; 4: 172–174.

CS.

Role of pharmacists in optimizing the use of anticancer drugs in the clinical setting. Integr Pharm Res Pract 2014; 3: 11–24.

Patel

Gurumurthy

Improving medication safety in oncology care: impact of clinical pharmacy interventions on optimizing patient safety.

Int J Clin Pharm 2019; 41: 981–992.

Lau

Stewart

Dooley

The ten most common adverse drug reactions (ADRs) in oncology patients: do they matter to you?

Support Care Cancer 2004; 12: 626–633.

Hutchison

Castleberry

The pharmacist’s new role as part of an interdisciplinary care team. J Am Soc Aging 2012; 35: 62–68.

Patel

Gurumurthy

Implementation and evaluation of medicine and therapeutic information service by clinical pharmacists in oncology care setting.

J Oncol Pharm Pract 2019; 25: 60–67.

Liekweg

Westfeld

Jaehde

From oncology pharmacy to pharmaceutical care: new contributions to multidisciplinary cancer care.

Support Care Cancer 2004; 12: 73–79.

10.

Holle

Boehnke Michaud

Oncology pharmacists in health care delivery: vital members of the cancer care team.

J Oncol Pract 2014; 10: e142–5.

11.

Holle

Harris

Chan

, et al. Pharmacists’ roles in oncology pharmacy services: results of a global survey. J Oncol Pharm Pract 2017; 23: 185–194.

12.

Bryk

Koontz

Mayor

, et al. Characterization of collaborative practice agreements held by hematopoietic stem cell transplant pharmacists. J Oncol Pharm Pract 2019; 25: 558–566.

13.

The World Bank. World Bank Country and Lending Groups, https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups (accessed 12 January 2020).

14.

El Hajj

Hamid

Breast cancer health promotion in Qatar: a survey of community pharmacists’ interests and needs. Int J Clin Pharm 2011; 33: 70–79.

15.

Xue

Schulman-Green

Czaplinski

, et al. Pain attitudes and knowledge among RNs, pharmacists, and physicians on an inpatient oncology service. Clin J Oncol Nurs 2007; 11: 687.

16.

Obeidat

Hawari

Amarin

, et al. Educational needs of oncology practitioners in a regional cancer center in the Middle East—improving the content of smoking cessation training programs. J Cancer Educ 2017; 32: 714–720.

17.

Abbott

Edwards

Whelan

, et al. Are community pharmacists equipped to ensure the safe use of oral anticancer therapy in the community setting? Results of a cross-country survey of community pharmacists in Canada. J Oncol Pharm Pract 2014; 20: 29–39.

18.

Suzuki

Abbott

Sakurai

, et al. Evaluation of community pharmacist ability to ensure the safe use of oral anticancer agents: a nationwide survey in Japan. Japan J Clin Oncol 2017; 47: 413–421.

19.

Chan

Patel

Siderov

, et al. Assessing biosimilar education needs among oncology pharmacy practitioners worldwide: an ISOPP Membership Survey. J Onco Pharm Pract 2020; 26: 11–21.

20.

International Society of Oncology Pharmacy Practitioners. Symposia and masterclasses, www.isopp.org/isopp-symposia (accessed 03 May 2020).

21.

AMA Victoria – Victorian Public Health Sector – Medical Specialists Enterprise Agreement 2018–2021, https://swarh2.com.au/assets/A/1230/8e05a7cdb952e796ee3faa15744e7f96/Medical%20Specialist%20EBA%20Attachment%20A%20March%2018.pdf (accessed 26 February 2020).

22.

American College of Physicians. Physician employment contract guide 2017, www.acponline.org/system/files/documents/running_practice/practice_management/human_resources/employment_contracts.pdf (accessed 27 February 2020).